Related references
Note: Only part of the references are listed.Analysis of the three-dimensional structure of the African horse sickness virus VP7 trimer by homology modelling
Shani Bekker et al.
VIRUS RESEARCH (2017)
Synthetic plant virology for nanobiotechnology and nanomedicine
John F. C. Steele et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
The case for plant-made veterinary immunotherapeutics
Edward Topp et al.
BIOTECHNOLOGY ADVANCES (2016)
Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
Valeria Lulla et al.
JOURNAL OF VIROLOGY (2016)
Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment
George P. Lomonossoff et al.
SCIENCE (2016)
Synthesis of empty african horse sickness virus particles
Sonja Maree et al.
VIRUS RESEARCH (2016)
African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014
Camilla T. Weyer et al.
EMERGING INFECTIOUS DISEASES (2016)
Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
Eva Calvo-Pinilla et al.
ANTIVIRAL RESEARCH (2015)
VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
Sandra G. P. van de Water et al.
JOURNAL OF VIROLOGY (2015)
Directed genetic modification of African horse sickness virus by reverse genetics
Elaine Vermaak et al.
SOUTH AFRICAN JOURNAL OF SCIENCE (2015)
Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
Yuta Kanai et al.
VACCINE (2014)
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
Berta Alberca et al.
VACCINE (2014)
Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation
Eva Calvo-Pinilla et al.
VIRUS RESEARCH (2014)
African horse sickness in naturally infected, immunised horses
C. T. Weyer et al.
EQUINE VETERINARY JOURNAL (2013)
A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles
Eva C. Thuenemann et al.
PLANT BIOTECHNOLOGY JOURNAL (2013)
Focus on: African horse sickness
Richard Hopley et al.
VETERINARY RECORD (2013)
Risk of introducing African horse sickness virus into the Netherlands by international equine movements
C. J. de Vos et al.
PREVENTIVE VETERINARY MEDICINE (2012)
An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses
H. El Garch et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Plant-made vaccines for humans and animals
Edward P. Rybicki
PLANT BIOTECHNOLOGY JOURNAL (2010)
In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6
Beate F. von Teichman et al.
VACCINE (2010)
Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseases
N. James MacLachlan et al.
VETERINARY RESEARCH (2010)
pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants
Frank Sainsbury et al.
PLANT BIOTECHNOLOGY JOURNAL (2009)
Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus
Alan J. Guthrie et al.
VACCINE (2009)
Equine travellers to the Olympic Games in Hong Kong 2008: A review of worldwide challenges to equine health, with particular reference to vector-borne diseases
C. Herholz et al.
EQUINE VETERINARY JOURNAL (2008)
Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals
Beate F. von Teichman et al.
VACCINE (2008)
Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe
K. E. Darpel et al.
VETERINARY RECORD (2007)
Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization
J. Maclean et al.
JOURNAL OF GENERAL VIROLOGY (2007)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
Share Paper
